Key facts
| Price (PPV) | 125.90 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | ropinirole |
| Class | Anti-parkinson drugs |
| ATC code | N04BC04 |
| Manufacturer | SUN PHARMACEUTICALS NORTH AFRICA S.A |
| Presentation | Boite de 84 |
| Nature | Médicament |
| Hospital price | 78.70 MAD |
| Data collected on | 9/8/2026 |
Indications
Maladie de Parkinson dans les conditions suivantes : - traitement de première intention en monothérapie pour différer la mise à la dopathérapie, - association à la lévodopa en cours d'évolution de la maladie lorsque l'effet de la dopathérapie s'épuise ou devient inconstant, et qu'apparaissent des fluctuations de l'effet thérapeutique (fluctuations de type "fin de dose" ou effets "on-off").
Psychoactive substance / dependence
Oui
Find an open pharmacy
On-call pharmacies near you
About Ranpirole 0.5 mg
Ranpirole 0.5 mg belongs to the anti-parkinson drugs therapeutic class. In Morocco, this drug is marketed by SUN PHARMACEUTICALS NORTH AFRICA S.A and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Ranpirole 0.5 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Ranpirole 0.5 mg
Answers to common questions from Moroccan patients about this drug.